期刊
AMERICAN JOURNAL OF PUBLIC HEALTH
卷 100, 期 1, 页码 24-32出版社
AMER PUBLIC HEALTH ASSOC INC
DOI: 10.2105/AJPH.2008.153767
关键词
-
资金
- Robert Wood Johnson Foundation (RWJF)
- University of California, Los Angeles [5K12AG001004]
- National Institute of Aging [5P30 AG028748]
- National Institute of Mental Health [K24MH072756]
- NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH072756] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [K12AG001004, P30AG028748] Funding Source: NIH RePORTER
Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial since regulations were liberalized by the Food and Drug Administration in 1997. We reviewed empirical evidence addressing the claims made in the policy debate for and against DTCA. This advertising has some benefits, but significant risks are evident as well, magnified by the prominence of DTCA in population-level health communications. To minimize potential harm and maximize the benefits of DTCA for population health, the quality and quantity of information should be improved to enable consumers to better self-identify whether treatment is indicated, more realistically appraise the benefits, and better attend to the risks associated with prescription drugs. We propose guidelines for improving the utility of prescription drug advertising. (Am J Public Health. 2010; 100:24-32. doi:10.2105/AJPH.2008.153767)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据